A pharmacovigilance study to determine risk of mortality in male and female patients with Alzheimer's disease using Rivastigmine
This thesis is submitted in partial fulfillment of the requirements for the degree of Bachelor of Pharmacy, 2023.
Autor principal: | Shehab, Habibul Mohsin |
---|---|
Outros Autores: | Yasmin, Hasina |
Formato: | Thesis |
Idioma: | English |
Publicado em: |
Brac University
2024
|
Assuntos: | |
Acesso em linha: | http://hdl.handle.net/10361/22683 |
Registos relacionados
-
Gender-specific Rhabdomyolysis risk in Alzheimer’s disease patients receiving memantine: a pharmacovigilance study
Por: Tabassum, Nadira
Publicado em: (2024) -
Signal detection of rhabdomyolysis and death for rivastigmine: a pharmacovigilance study
Por: Mahee, Sadique Abdal
Publicado em: (2024) -
Efficacy of Rivastigmine in Alzheimer’s disease- A structured seview
Por: Alim, Abdul
Publicado em: (2023) -
Signal detection of Rhabdomyolysis and death for galantamine: a pharmacovigilance study
Por: Karmaker, Swastika
Publicado em: (2024) -
A pharmacovigilance study on Donepezil: signal detection of rhabdomyolysis and death
Por: Jahan, Nusrat
Publicado em: (2023)